BioPharma Credit PLC (BPCR) — Cash Flow Quality Index
BioPharma Credit PLC (BPCR) has a Cash Flow Quality Index of 0.46x as of June 2025. Operating cash flow of $33.76 Million is below net income of $72.78 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BioPharma Credit PLC cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioPharma Credit PLC Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for BioPharma Credit PLC across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see BioPharma Credit PLC operating cash flow efficiency.
Annual Cash Flow Quality Index for BioPharma Credit PLC (2017–2024)
Year-by-year earnings quality comparison for BioPharma Credit PLC.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | $111.91 Million | $122.18 Million | ▼ -19.4% |
| 2023 | 1.14x | $123.18 Million | $108.45 Million | ▲ +12.4% |
| 2022 | 1.01x | $184.28 Million | $182.31 Million | ▼ -11.0% |
| 2021 | 1.14x | $96.44 Million | $84.96 Million | ▲ +74.2% |
| 2020 | 0.65x | $58.07 Million | $89.14 Million | ▼ -39.4% |
| 2019 | 1.08x | $131.52 Million | $122.33 Million | ▲ +12.3% |
| 2018 | 0.96x | $67.14 Million | $70.15 Million | ▲ +12.7% |
| 2017 | 0.85x | $23.07 Million | $27.16 Million | — |